文献リスト

1) Ronnback M, Fagerudd J, Forsblom C, et al. Altered age-related blood pressure pattern in type 1 diabetes. Circulation. 2004; 110: 1076-82

2) Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet. 1998; 351: 1755-62

3) UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998; 317: 703-13

4) Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus. Results of prospectively designed overviews of randomized trials. Arch Intern Med. 2005; 165: 1410-9

5) Mancia G. The association if hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction. Acta Diabetol. 2005; 42 Suppl 1: S17-25

6) Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007; 28: 1462-536

7) Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Hypertension. 2003; 42: 1206-52

8) American Diabetes Association. Standards of Medical Care in Diabetes-2007. Diabetes Care. 2007; 30: S4-41

9) 日本糖尿病学会, 編. 科学的根拠に基づく糖尿病診療ガイドライン. 改訂第2版. 東京: 南江堂; 2007

10) 日本高血圧学会高血圧治療ガイドライン作成委員会, 編. 高血圧治療ガイドライン2004. 東京: 日本高血圧学会; 2004

11) ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002; 288: 2981-97

12) Staessen JA, Li Y, Thijs L, et al. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res. 2005; 28: 385-407

13) Stratton IM, Cull CA, Adler AI, et al. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia. 2006; 49: 1761-9

14) Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006; 354: 1685- 97

15) Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and the diagnostic standard for metabolic syndrome. 日本内科学会雑誌. 2005; 94: 794-809

16) Mancia G, Facchetti R, Bombelli M, et al. Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension. 2005; 45: 1072-7

17) Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet. 2002; 359: 2072-7

18) Chiasson JL, Josse RG, Gomis R, et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003; 23: 486-94

19) Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004; 364: 685-96

20) Ninomiya T, Kubo M, Doi Y, et al. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study. Stroke. 2007; 38: 2063-9

21) Yamada T, Komatsu M, Komiya I, et al. Development, progression, and regression of microalbuminuria in Japanese patients with type 2 diabetes under tight glycemic and blood pressure control: the Kashiwa study. Diabetes Care. 2005; 28: 2733-8

22) Kennedy M, Solomon C, Manolio TA, et al. Risk factors for declining ankle-brachial index in men and women 65 years or older: the Cardiovascular Health Study. Arch Intern Med. 2005; 165: 1896-902

23) Ruggenenti P, Jassi A, LLieva AP, et al. Preventing microalbuminuria in type 2 diabetes. N Engl J Med. 2004; 351: 1941-51

24) Estacio RO, Coll JR, Tran ZV, et al. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. Am J Hypertens. 2006; 19: 1241-8

25) Kario K. “Cocktail" antihypertensive chronotherapy for perfect control of morning hypertension in diabetic patients. Inter Med. 2005; 44: 1211-2

26) Imai Y, Otsuka K, Kawano Y, et al. Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res. 2003; 26: 771-82

27) Little P, Barnett J, Barnsley L, et al. Comparison of acceptability of and preferences for different methods of measuring blood pressure in primary care. BMJ. 2002; 325: 258-9

28) Ashida T, Sugiyama T, Okuno S, et al. Relationship between home blood pressure measurement and medicationcompliance and name recognition of antihypertensive drugs. Hypertens Res. 2000; 23: 21-4

29) Halme L, Vesalainen R, Kaaja M, et al. Self-monitoring of blood pressure promotes achievement of blood pressure target in primary healthcare. Am J Hypertens. 2005; 18: 1415-20

30) Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999; 285: 539-46

31) Ohkubo T, Hozawa A, Yamaguchi J, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002; 20: 2183-9

32) Asayama K, Ohkubo T, Kikuya M, et al. Prediction of stroke by home “morning" versus “evening" blood pressure values: the Ohasama study. Hypertension. 2006; 48: 737-43

33) Chonan K, Kikuya M, Araki T, et al. Device for the self-measurement of blood pressure that can monitor blood pressure during sleep. Blood Press Monit. 2001; 6: 203-5

34) Hosohata K, Kikuya M, Ohkubo T, et al. Reproducibility of nocturnal blood pressure assessed by self-measurement of blood pressure at home. Hypertens Res. 2007; 30: 707-12

35) Kamoi K, Miyakoshi M, Soda S, et al. Usefulness of home blood pressure measurement in the morning in type 2 diabetic patients. Diabetes Care. 2002; 25: 2218-23

36) 佐藤 敦, 浅山 敬, 大久保孝義, 他. 第30回日本高血圧学会. 沖縄. 2007

37) Obara T, Ohkubo T, Kikuya M, et al. The current status of home and office blood pressure control among hypertensive patients with diabetes mellitus: the Japan Home Versus Office Blood Pressure Measurement Evaluation (J-HOME) study. Diabetes Res Clin Pract. 2006; 73: 276-83

38) Oliveria SA, Lapuerta P, McCarthy BD, et al. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002; 162: 413-20

39) Ohkubo T, Obara T, Funahashi J, et al. Control of blood pressure as measured at home and office, and comparison with physicians' assessment of control among treated hypertensive patients in Japan: First Report of the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) study. Hypertens Res. 2004; 27: 755-63

40) Ishikawa J, Kario K, Hoshide S, et al. Determinants of exaggerated difference in morning and evening blood pressure measured by self-measured blood pressure monitoring in medicated hypertensive patients: Jichi Morning Hypertension Research (J-MORE) Study. Am J Hypertens. 2005; 18: 958-65

41) Mancia G, Sega R, Bravi C, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995; 13: 1377-90

42) 高田紀子, 大久保孝義, 菊谷昌浩, 他. 第14回日本疫学会学術総会 P-131. 山形. 2004

43) Asayama K, Ohkubo T, Kikuya M, et al. Prediction of stroke by self-measurement of blood pressure at home versus casual screening blood pressure measurement in relation to the Joint National Committee 7 classification: the Ohasama study. Stroke. 2004; 35: 2356-61

44) Asayama K, Ohkubo T, Kikuya M, et al. Use of 2003 European Society of Hypertension-European Society of Cardiology guidelines for predicting stroke using self-measured blood pressure at home: the Ohasama study. Eur Heart J. 2005; 26: 2026-31

45) Niiranen T, Jula A, Kantola I, et al. Home-measured blood pressure is more strongly associated with atherosclerosis than clinic blood pressure: the Finn-HOME Study. J Hypertens. 2007; 25: 1225-31

46) Staessen JA, Den Hond E, Celis H, et al. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial. JAMA. 2004; 291: 955-64

47) Hosohata K, Saito S, Asayama K, et al. Progress report on The Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) study: status at February 2004. Clin Exp Hypertens. 2007; 29: 69-81

48) Fujiwara T, Nishimura T, Ohkuko T, et al. Rationale and design of HOMED-BP Study: hypertension objective treatment based on measurement by electrical devices of blood pressure study. Blood Press Monit. 2002; 7: 77-82

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp